DK0502956T3 - Fremstilling af en rekombinant human interleukin-1-inhibitor. - Google Patents

Fremstilling af en rekombinant human interleukin-1-inhibitor.

Info

Publication number
DK0502956T3
DK0502956T3 DK91900515.7T DK91900515T DK0502956T3 DK 0502956 T3 DK0502956 T3 DK 0502956T3 DK 91900515 T DK91900515 T DK 91900515T DK 0502956 T3 DK0502956 T3 DK 0502956T3
Authority
DK
Denmark
Prior art keywords
inhibitor
preparation
recombinant human
human interleukin
disclosed
Prior art date
Application number
DK91900515.7T
Other languages
Danish (da)
English (en)
Inventor
Robert C Thompson
Robert Hageman
Stephen P Eisenberg
David Dripps
Ronald Evans
Henryk Cudny
Original Assignee
Amgen Boulder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc filed Critical Amgen Boulder Inc
Application granted granted Critical
Publication of DK0502956T3 publication Critical patent/DK0502956T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK91900515.7T 1989-11-29 1990-11-29 Fremstilling af en rekombinant human interleukin-1-inhibitor. DK0502956T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44265289A 1989-11-29 1989-11-29

Publications (1)

Publication Number Publication Date
DK0502956T3 true DK0502956T3 (da) 1997-10-20

Family

ID=23757611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900515.7T DK0502956T3 (da) 1989-11-29 1990-11-29 Fremstilling af en rekombinant human interleukin-1-inhibitor.

Country Status (17)

Country Link
US (1) US5453490A (fi)
EP (1) EP0502956B1 (fi)
JP (1) JP3014007B2 (fi)
KR (1) KR0182819B1 (fi)
AT (1) ATE152172T1 (fi)
AU (1) AU651955B2 (fi)
BR (1) BR9007883A (fi)
CA (1) CA2068320C (fi)
DE (1) DE69030582T2 (fi)
DK (1) DK0502956T3 (fi)
ES (1) ES2103305T3 (fi)
FI (1) FI104733B (fi)
GR (1) GR3024031T3 (fi)
HK (1) HK1006856A1 (fi)
HU (1) HUT64582A (fi)
NO (1) NO305290B1 (fi)
WO (1) WO1991008285A1 (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6552170B1 (en) * 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5786331A (en) * 1994-02-02 1998-07-28 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5608035A (en) * 1994-02-02 1997-03-04 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5880096A (en) * 1994-02-02 1999-03-09 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5861476A (en) * 1994-02-02 1999-01-19 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5837495A (en) * 1994-10-13 1998-11-17 Applied Research Systems Ars Holding N.V. DNA encoding interleukin-1 antagonist
US5981713A (en) * 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
IT1270662B (it) * 1994-10-13 1997-05-07 Applied Research Systems Antagonista della interleuchina-1
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
ES2312179T3 (es) * 1996-12-06 2009-02-16 Amgen Inc. Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1.
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
TR201809008T4 (tr) 2001-06-26 2018-07-23 Amgen Fremont Inc Opgl ye karşi antikorlar.
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
DK1572946T3 (da) 2002-09-06 2012-07-02 Amgen Inc Terapeutisk humant monoklonalt anti-IL-1R1-antistof
CA2557910C (en) 2004-04-02 2012-05-29 Amgen Inc. Methods of reducing aggregation of il-1ra
TW200736277A (en) 2005-11-14 2007-10-01 Amgen Inc RANKL antibody-PTH/PTHrP chimeric molecules
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
US10105441B2 (en) * 2007-08-16 2018-10-23 The Schepens Eye Research Institute, Inc. Method for inhibiting or reducing dry eye disease by IL-1Ra
EP2217258B1 (en) 2007-11-14 2014-03-26 General Regeneratives Limited Use of interleukin-1 receptor antagonist as a myeloprotective agent
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
KR102080704B1 (ko) 2010-07-29 2020-02-24 세센 바이오, 아이엔씨. 키메라 il-1 수용체 유형 i 항진제 및 길항제들
WO2013016220A1 (en) 2011-07-22 2013-01-31 Amgen Inc. Il-17 receptor a is required for il-17c biology
WO2013019652A1 (en) * 2011-07-29 2013-02-07 Eleven Biotherapeutics, Inc. Purified proteins
EP2851429B1 (en) 2012-05-18 2019-07-24 Adda Biotech Inc. Protein and protein conjugate for diabetes treatment, and applications thereof
JP6450364B2 (ja) 2013-03-13 2019-01-09 セセン バイオ， インコーポレイテッド 眼送達のためのキメラサイトカイン製剤
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
AU2014345511A1 (en) 2013-11-11 2016-05-12 Ascendis Pharma A/S Relaxin prodrugs
US9833474B2 (en) 2013-11-26 2017-12-05 Biomet Biologies, LLC Methods of mediating macrophage phenotypes
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
WO2018022982A1 (en) 2016-07-29 2018-02-01 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
US11285196B2 (en) 2017-03-13 2022-03-29 Eslam Abbas Baseuny Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
EP3836954A1 (en) 2018-08-13 2021-06-23 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2220662A (en) * 1987-08-26 1990-01-17 Biogen Inc Biological materials,processes for producing biological materials and for using such materials in therapy
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
WO1991017184A1 (en) * 1990-04-27 1991-11-14 The Upjohn Company Modified interleukin-1 inhibitors
JPH05506986A (ja) * 1990-05-01 1993-10-14 カイロン　コーポレイション インターロイキン―１拮抗物質及びその利用

Also Published As

Publication number Publication date
NO922138D0 (no) 1992-05-29
JP3014007B2 (ja) 2000-02-28
KR0182819B1 (en) 1999-04-01
CA2068320C (en) 2000-10-17
FI922434A (fi) 1992-05-27
WO1991008285A1 (en) 1991-06-13
AU651955B2 (en) 1994-08-11
AU6900791A (en) 1991-06-26
KR920703792A (ko) 1992-12-18
JPH05503007A (ja) 1993-05-27
ATE152172T1 (de) 1997-05-15
CA2068320A1 (en) 1991-05-30
HUT64582A (en) 1994-01-28
NO305290B1 (no) 1999-05-03
HK1006856A1 (en) 1999-03-19
HU9201777D0 (en) 1992-12-28
BR9007883A (pt) 1992-09-29
ES2103305T3 (es) 1997-09-16
EP0502956A1 (en) 1992-09-16
FI104733B (fi) 2000-03-31
US5453490A (en) 1995-09-26
FI922434A0 (fi) 1992-05-27
GR3024031T3 (en) 1997-10-31
EP0502956A4 (en) 1992-12-09
NO922138L (no) 1992-05-29
EP0502956B1 (en) 1997-04-23
DE69030582T2 (de) 1998-06-25
DE69030582D1 (de) 1997-05-28

Similar Documents

Publication Publication Date Title
DK0502956T3 (da) Fremstilling af en rekombinant human interleukin-1-inhibitor.
IT8048102A0 (it) Procedimento di preparazione di un idrolisato di proteine purificato
IT1182721B (it) Procedimento di purificazione di proteine ossee
PT822199E (pt) Polipeptidos monopegilados no terminal-n e metodo para a sua preparacao
ITMI920569A0 (it) Procedimento per la fabbricazione di tastiere
NL300091I1 (nl) Interleukine-1 remmers.
FI894671A0 (fi) Reglerbar faestanordning.
IT8867187A0 (it) Procedimento per la fabbricazione di cemento
KR920700625A (ko) 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
DK377787D0 (da) Interferonfragmenter
IT1230333B (it) Procedimento per la fabbricazione di pezzi stampati ceramici.
IT8947842A0 (it) Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT8721560A0 (it) Procedimento per la purificazione di interferone.
IT1229522B (it) Procedimento per la preparazione di acido n fosfonometiliminodiacetico.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
IT9020860A0 (it) Procedimento per la depurazione fine di gas
IT8467785A0 (it) Procedimento per la produzione di tirosina
IT8719420A0 (it) Purificazione di interleuchina-1umana ricombinante.
IT1231506B (it) Procedimento per la purificazione di polieteri polioli.
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
IT8819919A0 (it) Procedimento perfezionato per laproduzione di componenti ceramici.
IT8421195A1 (it) Procedimento per la fabbricazione di magnesia refrattaria
IT8812432A0 (it) Procedimento per la fabbricazione di vetri stratificati
IT1217906B (it) Procedimento per la realizzazione di fogli autoadesivi